OMI Insider Transactions
Transaction Date (SEC Report) |
Reporting Name | Relationship | Shrs. Owned | Type | Acq./Disp. | Shrs. Transacted | Price() | Amount() |
---|---|---|---|---|---|---|---|---|
2024-03-15 | Bernocchi Perry A | officer: EVP, CEO,. Patient Direct | 194,591 | F-InKind | D | 14,946 | 24.99 | 373,501.00 |
2024-03-15 | Leon Jonathan A | officer: SVP, Corporate Treasurer | 89,673 | F-InKind | D | 3,086 | 24.99 | 77,119.00 |
2024-03-15 | Long Andrew G | officer: EVP, CEO P&HS | 249,780 | F-InKind | D | 22,785 | 24.99 | 569,397.00 |
2024-03-15 | Lowry Michael Wayne | officer: SVP, Corporate Controller | 79,222 | F-InKind | D | 3,086 | 24.99 | 77,119.00 |
2024-03-15 | Pesicka Edward A | director, officer: President & CEO | 799,670 | F-InKind | D | 58,126 | 24.99 | 1,452,569.00 |
2024-03-01 | Starck Daniel J | officer: EVP, Business Excellence | 105,058 | A-Award | A | 32,975 | 0.00 | 0.00 |
2024-03-01 | Sarkar Snehashish | other: Chief Information Officer | 73,439 | A-Award | A | 14,205 | 0.00 | 0.00 |
2024-03-01 | Pesicka Edward A | director, officer: President & CEO | 857,796 | A-Award | A | 148,134 | 0.00 | 0.00 |
2024-03-01 | Leon Jonathan A | officer: SVP, Corporate Treasurer | 92,759 | A-Award | A | 17,046 | 0.00 | 0.00 |
2024-03-01 | Galloway Heath H | officer: EVP,General Counsel & CorpSecy | 60,681 | A-Award | A | 24,351 | 0.00 | 0.00 |
2024-03-01 | Long Andrew G | officer: EVP, CEO P&HS | 272,565 | A-Award | A | 50,731 | 0.00 | 0.00 |
2024-03-01 | Lowry Michael Wayne | officer: SVP, Corporate Controller | 82,308 | A-Award | A | 10,654 | 0.00 | 0.00 |
2024-03-01 | Bernocchi Perry A | officer: EVP, CEO,. Patient Direct | 209,537 | A-Award | A | 44,643 | 0.00 | 0.00 |
2024-03-01 | Bruni Alexander J | officer: EVP, CFO | 65,808 | A-Award | A | 24,351 | 0.00 | 0.00 |
2024-02-27 | Lowry Michael Wayne | officer: SVP, Corporate Controller | 71,654 | S-Sale | D | 10,000 | 25.00 | 250,000.00 |
2024-02-20 | Leon Jonathan A | officer: SVP, Corporate Treasurer | 75,713 | S-Sale | D | 5,000 | 22.00 | 110,000.00 |
2024-02-07 | Galloway Heath H | officer: EVP,General Counsel & CorpSecy | 36,437 | S-Sale | D | 97 | 19.91 | 1,931.00 |
2024-02-07 | Galloway Heath H | officer: EVP,General Counsel & CorpSecy | 36,330 | F-InKind | D | 107 | 19.96 | 2,136.00 |
2024-01-17 | Leon Jonathan A | officer: SVP, Corporate Treasurer | 83,213 | S-Sale | D | 7,500 | 18.08 | 135,600.00 |
2024-01-17 | Leon Jonathan A | officer: SVP, Corporate Treasurer | 80,713 | G-Gift | D | 2,500 | 0.00 | 0.00 |
2023-12-29 | Bernocchi Perry A | officer: EVP, CEO,. Patient Direct | 164,894 | A-Award | A | 547 | 16.18 | 8,853.00 |
2023-12-29 | Galloway Heath H | officer: EVP,General Counsel & CorpSecy | 36,534 | A-Award | A | 55 | 16.18 | 890.10 |
2023-12-29 | Lowry Michael Wayne | officer: SVP, Corporate Controller | 81,654 | A-Award | A | 555 | 16.18 | 8,982.00 |
2023-12-29 | Sarkar Snehashish | other: Chief Information Officer | 59,234 | A-Award | A | 555 | 16.18 | 8,982.00 |
2023-12-29 | Pesicka Edward A | director, officer: President & CEO | 709,662 | A-Award | A | 366 | 16.18 | 5,923.00 |
2023-12-20 | Leon Jonathan A | officer: SVP, Corporate Treasurer | 93,213 | S-Sale | D | 5,000 | 21.34 | 106,700.00 |
2023-12-20 | Leon Jonathan A | officer: SVP, Corporate Treasurer | 90,713 | G-Gift | D | 2,500 | 0.00 | 0.00 |
2023-11-22 | Bernocchi Perry A | officer: EVP, CEO,. Patient Direct | 164,347 | S-Sale | D | 19,302 | 18.75 | 361,916.00 |
2023-11-20 | Leon Jonathan A | officer: SVP, Corporate Treasurer | 98,213 | S-Sale | D | 5,000 | 18.62 | 93,100.00 |
2023-11-15 | Sarkar Snehashish | 58,679 | F-InKind | D | 1,159 | 18.07 | 20,943.00 | |
2023-11-10 | Galloway Heath H | officer: EVP,General Counsel & CorpSecy | 36,479 | S-Sale | D | 5,500 | 17.57 | 96,635.00 |
2023-11-10 | Bruni Alexander J | officer: EVP, CFO | 41,457 | S-Sale | D | 12,668 | 17.57 | 222,577.00 |
2023-10-27 | Leon Jonathan A | officer: SVP, Corporate Treasurer | 103,213 | F-InKind | D | 390 | 14.10 | 5,499.00 |
2023-08-15 | Gomez Tammy L | officer: EVP, CHRO | 46,782 | F-InKind | D | 1,506 | 19.63 | 29,563.00 |
2023-08-15 | Bruni Alexander J | officer: EVP, CFO | 54,125 | F-InKind | D | 328 | 19.63 | 6,439.00 |
2023-07-27 | Sarkar Snehashish | 59,838 | A-Award | A | 13,624 | 0.00 | 0.00 | |
2023-06-30 | Lowry Michael Wayne | officer: SVP, Corporate Controller | 81,099 | A-Award | A | 739 | 16.24 | 11,998.00 |
2023-06-30 | Pesicka Edward A | director, officer: President & CEO | 709,296 | A-Award | A | 923 | 16.24 | 14,985.00 |
2023-06-30 | Bernocchi Perry A | officer: EVP, CEO,. Patient Direct | 183,649 | A-Award | A | 554 | 16.24 | 8,994.00 |
2023-06-30 | Galloway Heath H | officer: EVP,General Counsel & CorpSecy | 41,979 | A-Award | A | 56 | 16.24 | 909.20 |
2023-06-30 | Sarkar Snehashish | 46,214 | A-Award | A | 739 | 16.24 | 11,998.00 | |
2023-06-15 | Pesicka Edward A | director, officer: President & CEO | 758,445 | S-Sale | D | 27,488 | 19.24 | 528,913.00 |
2023-06-15 | Pesicka Edward A | director, officer: President & CEO | 752,608 | S-Sale | D | 5,837 | 19.24 | 112,281.00 |
2023-06-15 | Pesicka Edward A | director, officer: President & CEO | 747,153 | S-Sale | D | 5,455 | 19.23 | 104,903.00 |
2023-06-16 | Pesicka Edward A | director, officer: President & CEO | 741,316 | S-Sale | D | 5,837 | 19.28 | 112,527.00 |
2023-06-16 | Pesicka Edward A | director, officer: President & CEO | 713,828 | S-Sale | D | 27,488 | 19.27 | 529,798.00 |
2023-06-16 | Pesicka Edward A | director, officer: President & CEO | 708,373 | S-Sale | D | 5,455 | 19.28 | 105,161.00 |
2023-06-08 | Pesicka Edward A | director, officer: President & CEO | 904,861 | S-Sale | D | 118,928 | 21.19 | 2,520,120.00 |
2023-06-09 | Pesicka Edward A | director, officer: President & CEO | 785,933 | S-Sale | D | 118,928 | 20.79 | 2,472,941.00 |
2023-06-06 | Lowry Michael Wayne | officer: SVP, Corporate Controller | 80,360 | S-Sale | D | 10,000 | 21.11 | 211,100.00 |
2023-06-06 | Pesicka Edward A | director, officer: President & CEO | 1,142,716 | S-Sale | D | 118,927 | 20.86 | 2,480,544.00 |
2023-06-07 | Pesicka Edward A | director, officer: President & CEO | 1,023,789 | S-Sale | D | 118,927 | 21.56 | 2,564,554.00 |
2023-05-19 | Long Andrew G | officer: EVP, CEO P&HS | 221,834 | G-Gift | D | 115,555 | 0.00 | 0.00 |
2023-05-17 | Galloway Heath H | officer: EVP,General Counsel & CorpSecy | 41,923 | A-Award | A | 17,794 | 0.00 | 0.00 |
2023-05-17 | Galloway Heath H | officer: EVP,General Counsel & CorpSecy | 24,129 | D | 0 | 0.00 | 0.00 | |
2023-05-15 | Pace Nicholas J | officer: EVP, General Counsel | 267,095 | F-InKind | D | 4,947 | 18.73 | 92,657.00 |
2023-05-15 | Pesicka Edward A | director, officer: President & CEO | 1,261,643 | F-InKind | D | 18,555 | 18.73 | 347,535.00 |
2023-05-15 | Lowry Michael Wayne | officer: SVP, Corporate Controller | 90,360 | F-InKind | D | 928 | 18.73 | 17,381.00 |
2023-05-15 | Leon Jonathan A | officer: SVP, Corporate Treasurer | 103,603 | F-InKind | D | 1,407 | 18.73 | 26,353.00 |
2023-05-15 | Long Andrew G | officer: EVP, CEO P&HS | 337,389 | F-InKind | D | 8,266 | 18.73 | 154,822.00 |
2023-05-15 | Bruni Alexander J | officer: EVP, CFO | 54,453 | F-InKind | D | 1,641 | 18.73 | 30,736.00 |
2023-05-15 | Bernocchi Perry A | officer: EVP, CEO,. Patient Direct | 183,095 | F-InKind | D | 6,998 | 18.73 | 131,073.00 |
2023-05-15 | Starck Daniel J | officer: EVP, Business Excellence | 72,083 | F-InKind | D | 2,139 | 18.73 | 40,063.00 |
2023-05-12 | Kline Teresa L. | director | 14,057 | A-Award | A | 9,344 | 0.00 | 0.00 |
2023-05-12 | Johnson-Mills Rita | director | 14,057 | A-Award | A | 9,344 | 0.00 | 0.00 |
2023-05-12 | Rollins Carissa | director | 13,834 | A-Award | A | 9,344 | 0.00 | 0.00 |
2023-05-12 | Beck Mark A | director | 9,344 | A-Award | A | 9,344 | 0.00 | 0.00 |
2023-05-12 | Bingham Gwendolyn M | director | 9,344 | A-Award | A | 9,344 | 0.00 | 0.00 |
2023-05-12 | Henkel Robert J | director | 37,344 | A-Award | A | 9,344 | 0.00 | 0.00 |
2023-05-12 | Gardner-Smith Kenneth | director | 14,854 | A-Award | A | 9,344 | 0.00 | 0.00 |
2023-05-12 | Klemash Stephen W | director | 18,983 | A-Award | A | 9,344 | 0.00 | 0.00 |
2023-05-11 | Bernocchi Perry A | officer: EVP, CEO,. Patient Direct | 190,093 | F-InKind | D | 6,583 | 18.39 | 121,061.00 |
2023-05-11 | Bruni Alexander J | officer: EVP, CFO | 56,094 | F-InKind | D | 3,219 | 18.39 | 59,197.00 |
2023-05-11 | Leon Jonathan A | officer: SVP, Corporate Treasurer | 105,010 | F-InKind | D | 1,713 | 18.39 | 31,502.00 |
2023-05-11 | Long Andrew G | officer: EVP, CEO P&HS | 345,655 | F-InKind | D | 7,186 | 18.39 | 132,151.00 |
2023-05-11 | Lowry Michael Wayne | officer: SVP, Corporate Controller | 91,288 | F-InKind | D | 1,453 | 18.39 | 26,721.00 |
2023-05-11 | Pace Nicholas J | officer: EVP, General Counsel | 272,042 | F-InKind | D | 7,186 | 18.39 | 132,151.00 |
2023-05-11 | Pesicka Edward A | director, officer: President & CEO | 1,280,198 | F-InKind | D | 45,163 | 18.39 | 830,548.00 |
2023-03-22 | Leon Jonathan A | officer: SVP, Corporate Treasurer | 106,723 | S-Sale | D | 6,000 | 13.50 | 81,000.00 |
2023-03-15 | Pesicka Edward A | director, officer: President & CEO | 1,325,361 | F-InKind | D | 265,362 | 13.06 | 3,465,628.00 |
2023-03-15 | Pace Nicholas J | officer: EVP, General Counsel | 279,228 | F-InKind | D | 32,878 | 13.06 | 429,387.00 |
2023-03-15 | Long Andrew G | officer: EVP, CEO P&HS | 352,841 | F-InKind | D | 33,471 | 13.06 | 437,131.00 |
2023-03-15 | Lowry Michael Wayne | officer: SVP, Corporate Controller | 92,741 | F-InKind | D | 8,923 | 13.06 | 116,534.00 |
2023-03-15 | Leon Jonathan A | officer: SVP, Corporate Treasurer | 112,723 | F-InKind | D | 10,468 | 13.06 | 136,712.00 |
2023-03-01 | Sarkar Snehashish | 45,475 | A-Award | A | 35,622 | 0.00 | 0.00 | |
2023-03-01 | Starck Daniel J | officer: EVP, Business Excellence | 74,222 | A-Award | A | 52,624 | 0.00 | 0.00 |
2023-03-01 | Gomez Tammy L | officer: EVP, CHRO | 48,288 | A-Award | A | 32,384 | 0.00 | 0.00 |
2023-03-01 | Pesicka Edward A | director, officer: President & CEO | 1,590,723 | A-Award | A | 128,882 | 0.00 | 0.00 |
2023-03-01 | Pesicka Edward A | director, officer: President & CEO | 1,461,841 | A-Award | A | 178,109 | 0.00 | 0.00 |
2023-03-01 | Pace Nicholas J | officer: EVP, General Counsel | 312,106 | A-Award | A | 35,150 | 0.00 | 0.00 |
2023-03-01 | Pace Nicholas J | officer: EVP, General Counsel | 276,956 | A-Award | A | 42,099 | 0.00 | 0.00 |
2023-03-01 | Lowry Michael Wayne | officer: SVP, Corporate Controller | 101,664 | A-Award | A | 10,252 | 0.00 | 0.00 |
2023-03-01 | Lowry Michael Wayne | officer: SVP, Corporate Controller | 91,412 | A-Award | A | 11,335 | 0.00 | 0.00 |
2023-03-01 | Long Andrew G | officer: EVP, CEO P&HS | 386,312 | A-Award | A | 55,654 | 0.00 | 0.00 |
2023-03-01 | Long Andrew G | officer: EVP, CEO P&HS | 330,658 | A-Award | A | 139,249 | 0.00 | 0.00 |
2023-03-01 | Leon Jonathan A | officer: SVP, Corporate Treasurer | 123,191 | A-Award | A | 10,252 | 0.00 | 0.00 |
2023-03-01 | Leon Jonathan A | officer: SVP, Corporate Treasurer | 112,939 | A-Award | A | 17,811 | 0.00 | 0.00 |
2023-03-01 | Bruni Alexander J | officer: EVP, CFO | 59,313 | A-Award | A | 32,384 | 0.00 | 0.00 |
2023-03-01 | Bernocchi Perry A | officer: EVP, CEO,. Patient Direct | 196,676 | A-Award | A | 35,150 | 0.00 | 0.00 |
2023-03-01 | Bernocchi Perry A | officer: EVP, CEO,. Patient Direct | 161,526 | A-Award | A | 64,767 | 0.00 | 0.00 |
Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Inc. doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Inc. or anyone involved with Discounting Cash Flows Inc. will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.